A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes

Cancer Genetics and Cytogenetics

Volumn 199, Issue 1, 2010, Pages 1-8

  Aranaz, Paula ^a   Ormazábal, Cristina ^a   Hurtado, Cristina ^a   Erquiaga, Ignacio ^a   Calasanz, Maria J ^a   García Delgado, Marina ^a   Novo, Francisco J ^a   Vizmanos, José L ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; JANUS KINASE; JANUS KINASE 2; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE;

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC SCREENING; GERM LINE; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SEQUENCE; CASE CONTROL STUDY; CHEMISTRY; CHRONIC DISEASE; ENZYMOLOGY; EXON; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CASE-CONTROL STUDIES; CHRONIC DISEASE; EXONS; FEMALE; FUSION PROTEINS, BCR-ABL; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JANUS KINASE 2; MALE; MOLECULAR SEQUENCE DATA; MUTATION; MYELOPROLIFERATIVE DISORDERS; ONCOGENES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY;

EID: 77951904473     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.01.002     Document Type: Article

References (31)

1. Tefferi A., Vardiman J.W. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008, 22:14-22.
2. De Keersmaecker K., Cools J. Chronic myeloproliferative disorders: a tyrosine kinase tale. Leukemia 2006, 20:200-205.
3. Levine R.L., Gilliland D.G. Myeloproliferative disorders. Blood 2008, 112:2190-2198.
4. Macdonald D., Cross N.C. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology 2007, 74:81-88.
5. Tefferi A. Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era. Hematology Am Soc Hematol Educ Program 2006, 240-245.
6. Pardanani A., Fridley B.L., Lasho T.L., Gilliland D.G., Tefferi A. Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders. Blood 2008, 111:2785-2789.
7. Jones A.V., Chase A., Silver R.T., Oscier D., Zoi K., Wang Y.L., Cario H., Pahl H.L., Collins A., Reiter A., Grand F., Cross N.C. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 2009, 41:446-449.
8. Kilpivaara O., Mukherjee S., Schram A.M., Wadleigh M., Mullally A., Ebert B.L., Bass A., Marubayashi S., Heguy A., Garcia-Manero G., Kantarjian H., Offit K., Stone R.M., Gilliland D.G., Klein R.J., Levine R.L. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 2009, 41:455-459.
9. Olcaydu D., Harutyunyan A., Jäger R., Berg T., Gisslinger B., Pabinger I., Gisslinger H., Kralovics R. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 2009, 41:450-454.
10. Bellanné-Chantelot C., Chaumarel I., Labopin M., Bellanger F., Barbu V., De Toma C., Delhommeau F., Casadevall N., Vainchenker W., Thomas G., Najman A. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood 2006, 108:346-352.
11. Landgren O., Goldin L.R., Kristinsson S.Y., Helgadottir E.A., Samuelsson J., Björkholm M. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood 2008, 112:2199-2204.
12. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
13. Ruhe J.E., Streit S., Hart S., Wong C.H., Specht K., Knyazev P., Knyazeva T., Tay L.S., Loo H.L., Foo P., Wong W., Pok S., Lim S.J., Ong H., Luo M., Ho H.K., Peng K., Lee T.C., Bezler M., Mann C., Gaertner S., Hoefler H., Iacobelli S., Peter S., Tay A., Brenner S., Venkatesh B., Ullrich A. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Res 2007, 67:11368-11376.
14. Tomasson M.H., Xiang Z., Walgren R., Zhao Y., Kasai Y., Miner T., Ries R.E., Lubman O., Fremont D.H., McLellan M.D., Payton J.E., Westervelt P., Dipersio J.F., Link D.C., Walter M.J., Graubert T.A., Watson M., Baty J., Heath S., Shannon W.D., Nagarajan R., Bloomfield C.D., Mardis E.R., Wilson R.K., Ley T.J. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood 2008, 111:4797-4808.
15. Loriaux M.M., Levine R.L., Tyner J.W., Frohling S., Scholl C., Stoffregen E.P., Wernig G., Erickson H., Eide C.A., Berger R., Bernard O.A., Griffin J.D., Stone R.M., Lee B., Meyerson M., Heinrich M.C., Deininger M.W., Gilliland D.G., Druker B.J. High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia. Blood 2008, 111:4788-4796.
16. Brown J.R., Levine R.L., Thompson C., Basile G., Gilliland D.G., Freedman A.S. Systematic genomic screen for tyrosine kinase mutations in CLL. Leukemia 2008, 22:1966-1969.
17. Tyner J.W., Loriaux M.M., Erickson H., Eide C.A., Deininger J., Macpartlin M., Willis S.G., Lange T., Druker B.J., Kovacsovics T., Maziarz R., Gattermann N., Deininger M.W. High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia. Leukemia 2008, 23:406-409.
18. Jones A.V., Kreil S., Zoi K., Waghorn K., Curtis C., Zhang L., Score J., Seear R., Chase A.J., Grand F.H., White H., Zoi C., Loukopoulos D., Terpos E., Vervessou E.C., Schultheis B., Emig M., Ernst T., Lengfelder E., Hehlmann R., Hochhaus A., Oscier D., Silver R.T., Reiter A., Cross N.C. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005, 106:2162-2168.
19. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
20. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a Web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
21. Schnittger S., Kohl T.M., Leopold N., Schoch C., Wichmann H.E., Kern W., Lohse P., Hiddemann W., Haferlach T., Spiekermann K. D324N single-nucleotide polymorphism in the FLT3 gene is associated with higher risk of myeloid leukemias. Genes Chromosomes Cancer 2006, 45:332-337.
22. Pastinen T., Ge B., Hudson T.J. Influence of human genome polymorphism on gene expression. Hum Mol Genet 2006, 15(Spec No 1):R9-R16.
23. Gondek L.P., Dunbar A.J., Szpurka H., McDevitt M.A., Maciejewski J.P. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD. PLoS ONE 2007, 2:e1225.
24. El-Omar E.M., Ng M.T., Hold G.L. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 2008, 27:244-252.
25. Score J., Walz C., Jovanovic J.V., Jones A.V., Waghorn K., Hidalgo-Curtis C., Lin F., Grimwade D., Grand F., Reiter A., Cross N.C. Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctions. Leukemia 2009, 23:332-339.
26. Campbell P.J. Somatic and germline genetics at the JAK2 locus. Nat Genet 2009, 41:385-386.
27. Walters D.K., Mercher T., Gu T.L., O'Hare T., Tyner J.W., Loriaux M., Goss V.L., Lee K.A., Eide C.A., Wong M.J., Stoffregen E.P., McGreevey L., Nardone J., Moore S.A., Crispino J., Boggon T.J., Heinrich M.C., Deininger M.W., Polakiewicz R.D., Gilliland D.G., Druker B.J. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 2006, 10:65-75.
28. Flex E., Petrangeli V., Stella L., Chiaretti S., Hornakova T., Knoops L., Ariola C., Fodale V., Clappier E., Paoloni F., Martinelli S., Fragale A., Sanchez M., Tavolaro S., Messina M., Cazzaniga G., Camera A., Pizzolo G., Tornesello A., Vignetti M., Battistini A., Cavé H., Gelb B.D., Renauld J.C., Biondi A., Constantinescu S.N., Foa R., Tartaglia M. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008, 205:751-758.
29. Zhao L., Ma Y., Seemann J., Huang L.J. A regulating role of JAK2 FERM domain in hyperactivation of JAK2(V617F). Biochem J 2009 Nov 24, [Epub ahead of print].
30. Kiyoi H., Yamaji S., Kojima S., Naoe T. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Leukemia 2007, 21:574-576.
31. Fröhling S., Scholl C., Levine R.L., Loriaux M., Boggon T.J., Bernard O.A., Berger R., Döhner H., Döhner K., Ebert B.L., Teckie S., Golub T.R., Jiang J., Schittenhelm M.M., Lee B.H., Griffin J.D., Stone R.M., Heinrich M.C., Deininger M.W., Druker B.J., Gilliland D.G. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell 2007, 12:501-513.